For the first target addressed in the partnership, the two companies reported the successful delivery of AI-designed, ...

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing ...

The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical ...

Jerry Keybl, senior vice-president, Biopharma Products and Strategy, Avantor, discusses innovations in biomanufacturing and ...

Radiopharmaceuticals are moving from their standard use of treating superficial tumors into radio drug conjugates that target ...

A new nuclear magnetic resonance method reveals real-time, coordinated changes in nanoemulsion drugs, improving noninvasive ...

Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the ...

The investment will expand the company’s manufacturing and packaging capabilities at its Maple Grove, Minn. site, which Bora ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial ...

ESTEVE CDMO's acquisition of Regis Technologies expands its US API contract development and manufacturing services, enhancing ...

Orforglipron showed clinically meaningful results at 72 weeks, after three doses, in a pool of more than 3000 adults.

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...